Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study-Reference-Cited by-同舟云学术

Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study

Published:2023-09 Issue:9 Volume:5 Page:e542-e552
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Papp Kim,Warren Richard B,Green Lawrence,Reich Kristian,Langley Richard G,Paul Carle,Asahina Akihiko,Johnson Lynne,Arora Vipin,Osuntokun Olawale,Lebwohl Mark

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference31 articles.

1. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013;Karimkhani;JAMA Dermatol,2017

2. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003–2011;Armstrong;PLoS One,2012

3. Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis;Gordon;N Engl J Med,2016

4. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: results from the CLEAR study;Blauvelt;J Am Acad Dermatol,2017

5. Secukinumab in plaque psoriasis--results of two phase 3 trials;Langley;N Engl J Med,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study;Clinical Pharmacology in Drug Development;2024-09-04

2. Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning;Clinical Gastroenterology and Hepatology;2024-08

3. Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond;Expert Opinion on Pharmacotherapy;2024-06-12

4. Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications;Cytokine & Growth Factor Reviews;2024-06

5. Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis;Journal of Personalized Medicine;2024-05-16